Monopar Therapeutics short interest in 2026
In 2026, Monopar Therapeutics's disclosed short interest ran from 19.14% of shares outstanding on 15 Jan 2026 to 12.58% on 15 Sep 2026, a change of -6.56 percentage points. The year's high was 25.75% on 15 Apr 2026 and its low 12.58% on 15 Sep 2026, averaging 20.83% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 12.54 days on 15 Jun 2026. Full history: Monopar Therapeutics.
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 19.14% (15 Jan 2026)
- End of year
- 12.58% (15 Sep 2026)
- Change
- -6.56 pp
- High
- 25.75% (15 Apr 2026)
- Low
- 12.58% (15 Sep 2026)
- Average
- 20.83%
- Highest days to cover
- 12.54 (15 Jun 2026)
- SEC filings marked
- 6
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 19.14% | 4.07 | |
| 30 Jan 2026 | 20.28% | 4.26 | |
| 13 Feb 2026 | 22.54% | 5.11 | |
| 27 Feb 2026 | 23.80% | 10.83 | |
| 13 Mar 2026 | 24.74% | 10.45 | |
| 31 Mar 2026 | 25.17% | 7.98 | 10-K filed, results (8-K) |
| 15 Apr 2026 | 25.75% | 9.34 | |
| 30 Apr 2026 | 24.96% | 10.60 | |
| 15 May 2026 | 23.45% | 8.05 | 10-Q filed, results (8-K) |
| 29 May 2026 | 23.60% | 8.53 | |
| 15 Jun 2026 | 23.28% | 12.54 | |
| 30 Jun 2026 | 22.71% | 8.61 | |
| 15 Jul 2026 | 20.33% | 5.94 | |
| 31 Jul 2026 | 15.87% | 3.40 | |
| 14 Aug 2026 | 13.22% | 3.48 | 10-Q filed, results (8-K) |
| 31 Aug 2026 | 12.70% | 4.54 | |
| 15 Sep 2026 | 12.58% | 7.20 |
See also: Monopar Therapeutics's full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.